H.R. 5950 · 117th Congress
Improving Patient Access to Care and Treatment Act
- Stage
- In committee
- Sponsor
- Madeleine Dean
- Introduced
- 2021-11-12
- Latest action
- 2022-11-01 · Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Summary
Improving Patient Access to Care and Treatment Act
This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.